BD&L teams are under increasing pressure to find the right in-licensing and acquisition opportunities quickly, often in unfamiliar therapeutic areas and amid a growing flood of assets. In this complexity, teams can often fall to reactive, ad hoc approaches to BD&L, but this risks wasted time, missed opportunities, and misalignment between end decisions and overall company goals.
To help teams focus their BD&L approach, rule out poor-fit opportunities early, and direct their resources where success is most likely, we’ve put together an in-depth guide.
Download the complete guidebook to learn: